Construction and Validation of a Tumor Microenvironment-Based Scoring System to Evaluate Prognosis and Response to Immune Checkpoint Inhibitor Therapy in Lung Adenocarcinoma Patients

Background: Lung cancer is among the most dangerous malignant tumors to human health. Lung adenocarcinoma (LUAD) accounts for about 40% of all lung cancers. Accumulating evidence suggests that the tumor microenvironment (TME) is a crucial regulator of carcinogenesis and therapeutic efficacy in LUAD....

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Pinzheng, Xu, Linfeng, Jin, Mingming, Li, Lixi, Ke, Yizhong, Zhang, Min, Zhang, Kairui, Lu, Kongyao, Huang, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222903/
https://www.ncbi.nlm.nih.gov/pubmed/35741714
http://dx.doi.org/10.3390/genes13060951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222903/
https://www.ncbi.nlm.nih.gov/pubmed/35741714
http://dx.doi.org/10.3390/genes13060951

Ejemplares similares